Nvidia, Moderna, Lucid, Dominari Holdings, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Benzinga
2025.04.01 03:01
portai
I'm PortAI, I can summarize articles.

The stock market faced a challenging day, with the S&P 500 ending 0.5% higher at 5,611.85, despite a 7% decline in March. Nvidia's stock fell 1.18% as it plans to invest billions in the U.S. supply chain. Moderna's shares tumbled 8.90% following an FDA shakeup. Lucid's stock rose 4.31% due to increased orders from former Tesla customers. Dominari's shares dropped 16.32% after a Bitcoin mining deal announcement. Tesla's stock decreased by 1.67%, but Elon Musk remains optimistic about the company's future.

The stock market faced a challenging day as risk sentiment remained under pressure on Wall Street. TheS&P 500experienced a volatile session, hitting its lowest point in over six months before recovering some losses. The S&P ended the day 0.5% higher at 5,611.85. Despite this, the index is on track for its worst month since September 2022, with a 7% decline in March. The Dow Jones Industrial Average was up 1% at 42,001.76 for the day.

Meanwhile, tech stocks struggled, with theNasdaq 100dropping 0.14% for the day at 17,299.29 as semiconductor stocks weighed heavily on the sector.

These are the top stocks that gained the attention of retail traders and investors throughout the day.

Nvidia Corporation NVDA

Nvidia’s stock fell 1.18% to close at $108.38, with an intraday high of $110.96 and a low of $103.65. The stock’s 52-week range is between $153.13 and $75.61. The company announced plans to invest billions in the U.S. supply chain over the next four years. CEO Jensen Huang stated that the investment is possible due to suppliers likeTaiwan Semiconductor Manufacturing Companyand Foxconn.

Moderna, Inc. MRNA

Moderna’s shares tumbled 8.90% to $28.35, with a high of $28.95 and a low of $26.80, marking a new 52-week low. The decline followed a shakeup at the U.S. Food and Drug Administration, withPeter Marksresigning from his role at the FDA's Center for Biologics Evaluation and Research.

See Also:Mark Cuban Warns Of ‘Red Rural Recession’ As Hundreds Of Small Town MAGA Supporters Reportedly Lose Federal Jobs – Benzinga

Lucid Group, Inc. LCID

Lucid’s stock rose 4.31% to $2.42, reaching a high of $2.44 and a low of $2.21. The 52-week range is $4.43 to $1.93. The increase came after bullish commentary from a company executive, who noted a "dramatic uptick" in orders from formerTesla Inc.customers.

Dominari Holdings Inc. DOMH

Dominari’s shares fell 16.32% to $4, with a high of $5.46 and a low of $3.84. The stock’s 52-week range is $13.58 to $0.83. The decline followed the announcement of a Bitcoin BTC/USD mining deal withHut 8 Corpand a registered direct offering.

Tesla, Inc. TSLA

Tesla’s stock decreased by 1.67% to $259.16, with an intraday high of $260.56 and a low of $243.36. The 52-week range is $488.54 to $138.8. Despite challenges,Elon Muskremains optimistic about Tesla’s future, viewing the current situation as a buying opportunity.

Image via Shutterstock

Prepare for the day’s tradingwith top premarket movers and newsby Benzinga.

Benzinga Edge Stock Rankings show Lucid with a 97th percentile growth score — curious how Tesla compares? Find out here.

Read Next:

  • China’s Chagee Files For US IPO; What Investors Need To Know

This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal